Note the date of the report, but here are some likely out of date numbers. When looking at peak sales, indications may be narrower now after some P3 trial results but also reimbursement prices might be higher. Don't know, just some ball park stuff from an analyst as a point in time. I'm sure there are newer reports from BP but have spent enough time on this for now. @otherperspective put out some numbers the other week on some of these indications.
Valuation, page-54
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |